Logo image of ALGM

ALLEGRO MICROSYSTEMS INC (ALGM) Stock Fundamental Analysis

USA - NASDAQ:ALGM - US01749D1054 - Common Stock

24.71 USD
-0.57 (-2.27%)
Last: 11/14/2025, 8:00:00 PM
24.71 USD
0 (0%)
After Hours: 11/14/2025, 8:00:00 PM
Fundamental Rating

4

Taking everything into account, ALGM scores 4 out of 10 in our fundamental rating. ALGM was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of ALGM is average, but there are quite some concerns on its profitability. ALGM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALGM had positive earnings in the past year.
In the past year ALGM had a positive cash flow from operations.
Of the past 5 years ALGM 4 years were profitable.
ALGM had a positive operating cash flow in each of the past 5 years.
ALGM Yearly Net Income VS EBIT VS OCF VS FCFALGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

1.2 Ratios

ALGM has a worse Return On Assets (-2.05%) than 60.71% of its industry peers.
ALGM has a Return On Equity (-3.00%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.05%
ROE -3%
ROIC N/A
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ALGM Yearly ROA, ROE, ROICALGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

With a Gross Margin value of 44.61%, ALGM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
ALGM's Gross Margin has improved in the last couple of years.
ALGM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
ALGM Yearly Profit, Operating, Gross MarginsALGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40

6

2. Health

2.1 Basic Checks

ALGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALGM has been reduced compared to 1 year ago.
Compared to 5 years ago, ALGM has less shares outstanding
ALGM has a worse debt/assets ratio than last year.
ALGM Yearly Shares OutstandingALGM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ALGM Yearly Total Debt VS Total AssetsALGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

ALGM has an Altman-Z score of 7.17. This indicates that ALGM is financially healthy and has little risk of bankruptcy at the moment.
ALGM has a Altman-Z score of 7.17. This is in the better half of the industry: ALGM outperforms 67.86% of its industry peers.
The Debt to FCF ratio of ALGM is 5.05, which is a neutral value as it means it would take ALGM, 5.05 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.05, ALGM perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
ALGM has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
ALGM has a Debt to Equity ratio (0.30) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.05
Altman-Z 7.17
ROIC/WACCN/A
WACC10.79%
ALGM Yearly LT Debt VS Equity VS FCFALGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.89 indicates that ALGM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.89, ALGM is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
ALGM has a Quick Ratio of 2.48. This indicates that ALGM is financially healthy and has no problem in meeting its short term obligations.
ALGM has a Quick ratio of 2.48. This is in the better half of the industry: ALGM outperforms 61.61% of its industry peers.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 2.48
ALGM Yearly Current Assets VS Current LiabilitesALGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

The earnings per share for ALGM have decreased strongly by -48.53% in the last year.
ALGM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -32.49% yearly.
Looking at the last year, ALGM shows a decrease in Revenue. The Revenue has decreased by -7.23% in the last year.
Measured over the past years, ALGM shows a small growth in Revenue. The Revenue has been growing by 2.21% on average per year.
EPS 1Y (TTM)-48.53%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%14.36%

3.2 Future

ALGM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.39% yearly.
The Revenue is expected to grow by 19.38% on average over the next years. This is quite good.
EPS Next Y121.25%
EPS Next 2Y102.66%
EPS Next 3Y87.39%
EPS Next 5YN/A
Revenue Next Year21.69%
Revenue Next 2Y18.29%
Revenue Next 3Y19.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALGM Yearly Revenue VS EstimatesALGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
ALGM Yearly EPS VS EstimatesALGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 70.60, which means the current valuation is very expensive for ALGM.
The rest of the industry has a similar Price/Earnings ratio as ALGM.
The average S&P500 Price/Earnings ratio is at 25.89. ALGM is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 25.07 indicates a quite expensive valuation of ALGM.
ALGM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALGM is cheaper than 65.18% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, ALGM is valued a bit cheaper.
Industry RankSector Rank
PE 70.6
Fwd PE 25.07
ALGM Price Earnings VS Forward Price EarningsALGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

ALGM's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as ALGM.
Industry RankSector Rank
P/FCF 80.33
EV/EBITDA 86.81
ALGM Per share dataALGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ALGM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALGM's earnings are expected to grow with 87.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y102.66%
EPS Next 3Y87.39%

0

5. Dividend

5.1 Amount

ALGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALLEGRO MICROSYSTEMS INC

NASDAQ:ALGM (11/14/2025, 8:00:00 PM)

After market: 24.71 0 (0%)

24.71

-0.57 (-2.27%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)01-28 2026-01-28/bmo
Inst Owners80.12%
Inst Owner Change-1.22%
Ins Owners0.62%
Ins Owner Change0.47%
Market Cap4.57B
Revenue(TTM)788.39M
Net Income(TTM)-28.37M
Analysts83.33
Price Target37.49 (51.72%)
Short Float %6.95%
Short Ratio4.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.14%
Min EPS beat(2)3.13%
Max EPS beat(2)5.14%
EPS beat(4)4
Avg EPS beat(4)7.84%
Min EPS beat(4)3.13%
Max EPS beat(4)17.65%
EPS beat(8)8
Avg EPS beat(8)15.73%
EPS beat(12)12
Avg EPS beat(12)11.98%
EPS beat(16)16
Avg EPS beat(16)10.58%
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)0.84%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-1.08%
Max Revenue beat(4)2.03%
Revenue beat(8)3
Avg Revenue beat(8)-0.39%
Revenue beat(12)3
Avg Revenue beat(12)-0.55%
Revenue beat(16)6
Avg Revenue beat(16)-0.1%
PT rev (1m)-2.86%
PT rev (3m)-2.65%
EPS NQ rev (1m)3.49%
EPS NQ rev (3m)1.06%
EPS NY rev (1m)-0.76%
EPS NY rev (3m)-0.84%
Revenue NQ rev (1m)3.93%
Revenue NQ rev (3m)3.66%
Revenue NY rev (1m)2.57%
Revenue NY rev (3m)3.15%
Valuation
Industry RankSector Rank
PE 70.6
Fwd PE 25.07
P/S 5.8
P/FCF 80.33
P/OCF 48.56
P/B 4.84
P/tB 9.34
EV/EBITDA 86.81
EPS(TTM)0.35
EY1.42%
EPS(NY)0.99
Fwd EY3.99%
FCF(TTM)0.31
FCFY1.24%
OCF(TTM)0.51
OCFY2.06%
SpS4.26
BVpS5.1
TBVpS2.65
PEG (NY)0.58
PEG (5Y)N/A
Graham Number6.34
Profitability
Industry RankSector Rank
ROA -2.05%
ROE -3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.61%
FCFM 7.22%
ROA(3y)6.9%
ROA(5y)7.3%
ROE(3y)8.35%
ROE(5y)8.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.77%
GM growth 5Y1.99%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 5.05
Debt/EBITDA 5.12
Cap/Depr 57.39%
Cap/Sales 4.72%
Interest Coverage N/A
Cash Conversion 168.55%
Profit Quality N/A
Current Ratio 3.89
Quick Ratio 2.48
Altman-Z 7.17
F-Score3
WACC10.79%
ROIC/WACCN/A
Cap/Depr(3y)131.89%
Cap/Depr(5y)124.81%
Cap/Sales(3y)8.59%
Cap/Sales(5y)8.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.53%
EPS 3Y-32.49%
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y121.25%
EPS Next 2Y102.66%
EPS Next 3Y87.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.23%
Revenue growth 3Y-1.93%
Revenue growth 5Y2.21%
Sales Q2Q%14.36%
Revenue Next Year21.69%
Revenue Next 2Y18.29%
Revenue Next 3Y19.38%
Revenue Next 5YN/A
EBIT growth 1Y-113.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.77%
EBIT Next 3Y83.95%
EBIT Next 5YN/A
FCF growth 1Y-26.17%
FCF growth 3Y-37.77%
FCF growth 5Y-10.31%
OCF growth 1Y-52.4%
OCF growth 3Y-26.53%
OCF growth 5Y-5.33%

ALLEGRO MICROSYSTEMS INC / ALGM FAQ

What is the ChartMill fundamental rating of ALLEGRO MICROSYSTEMS INC (ALGM) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGM.


Can you provide the valuation status for ALLEGRO MICROSYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to ALLEGRO MICROSYSTEMS INC (ALGM). This can be considered as Fairly Valued.


How profitable is ALLEGRO MICROSYSTEMS INC (ALGM) stock?

ALLEGRO MICROSYSTEMS INC (ALGM) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ALLEGRO MICROSYSTEMS INC (ALGM) stock?

The Price/Earnings (PE) ratio for ALLEGRO MICROSYSTEMS INC (ALGM) is 70.6 and the Price/Book (PB) ratio is 4.84.


What is the expected EPS growth for ALLEGRO MICROSYSTEMS INC (ALGM) stock?

The Earnings per Share (EPS) of ALLEGRO MICROSYSTEMS INC (ALGM) is expected to grow by 121.25% in the next year.